v3.20.4
Collaborations (Tables)
 12 Months Ended
Dec. 31, 2020
Janssen Biotech, Inc  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Janssen and AbbVie:
years ended December 31 (in millions)202020192018
United States - Janssen's share of profits (included in cost of products sold)$2,012 $1,803 $1,372 
International - AbbVie's share of profits (included in net revenues)1,009 844 622 
Global - AbbVie's share of other costs (included in respective line items)295 321 326 
Genentech, Inc.  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Genentech and AbbVie:
years ended December 31 (in millions)202020192018
Genentech's share of profits, including royalties (included in cost of products sold)$533 $320 $141 
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)46 41 27 
AbbVie's share of development costs (included in R&D)129 128 160